Author(s): Zahra N. Hachim, Shakir M. Alwan, Mayada H. Al-Qaisi


DOI: 10.52711/0974-360X.2024.00039   

Address: Zahra N. Hachim1*, Shakir M. Alwan2, Mayada H. Al-Qaisi1
1Pharmaceutical Chemistry Department, College of Pharmacy, Al-Mustansyriah University.
2Department of Pharmacy, Al-Farabi University Collage.
*Corresponding Author

Published In:   Volume - 17,      Issue - 1,     Year - 2024

Newer cephalosporins that can be orally administered with significant oral bioavailability and resist ß-lactamases are continuously and significantly requested. A method of using a potent third-generation cephalosporin, ceftizoxime, was suggested to synthesize new dipeptide derivatives. These derivatives were successfully synthesized by linking a dipeptide moiety, which includes L-Tryptophan-L-valine, L-Tryptophan-L-alanine, L-Tryptophan-L-histidine, and L-Tryptophan-L-phenylalanine as dipeptides to the aminothiazole moiety of ceftizoxime by an amide bond. Their chemical structures were confirmed by spectral analysis, including 1H-NMR,13CNMR, and FT-IR spectroscopy. Molecular docking for these new derivatives was performed on penicillin-binding proteins (PBPs) type 2a (3ZG0) of Methicillin-resistant Staphylococcus aureus, type 2X (5OJ0) of Streptococcus pneumonia and type 1b (5HLA) of E. coli, and has recorded higher affinity binding represented as PLP fitness on target enzymes. The binding scores were significant and may indicate better antimicrobial activities when compared with ceftizoxime. This improvement in affinity binding can be explained by the presence of indole and/or imidazole moieties in those derivatives. The indole and imidazole moieties are actual pharmacophores with various biological activities and may contribute to affinity binding, and the derivatives are considered molecular hybrids. Furthermore, a preliminary evaluation of the antibacterial activity of the synthesized derivatives was performed against two significant bacterial species (MRSA and E. coli), which showed better activity in compression to ceftizoxime. Moreover, the derivatives were tested on the protein oligopeptide (POT) family system and have recorded very interesting results for possible oral absorption when compared with Ceftizoxime, Val-acyclovir, and Val-Val-Acyclovir, as reference drugs. The Swiss ADME server was also used to analyze the pharmacokinetic characteristics and identify those likely to be absorbed orally.

Cite this article:
Zahra N. Hachim, Shakir M. Alwan, Mayada H. Al-Qaisi. Design, Molecular Docking, Synthesis, and Antimicrobial Evaluation of new Dipeptide derivatives of Ceftizoxime sodium. Research Journal of Pharmacy and Technology. 2024; 17(1):249-8. doi: 10.52711/0974-360X.2024.00039

Zahra N. Hachim, Shakir M. Alwan, Mayada H. Al-Qaisi. Design, Molecular Docking, Synthesis, and Antimicrobial Evaluation of new Dipeptide derivatives of Ceftizoxime sodium. Research Journal of Pharmacy and Technology. 2024; 17(1):249-8. doi: 10.52711/0974-360X.2024.00039   Available on:

1.    Kasai M, Hatano S, Kitagawa M, Yoshimi A, Nishimura K ichi, Mori N, et al. AS-924, a novel orally active bifunctional prodrug of ceftizoxime. Synthesis and relationship between physicocghemical properties and oral absorption. Chemical and Pharmaceutical Bulletin (Tokyo). 1999; 47(8):1081–8.
2.    Butler MS. Natural products to drugs: natural product derived compounds in clinical trials. Natural Product Reports. 2005; 22(2): 162–95.
3.    Mori N, Kodama T, Sakai A, Suzuki T, Sugihara T, Yamaguchi S, et al. AS-924, a novel, orally active, bifunctional prodrug of    ceftizoxime: physicochemical properties, oral absorption in animals, and antibacterial activity. International Journal of Antimicrobial Agents. 2001; 18(5): 451–61.
4.    Dunn GL. Ceftizoxime and other third-generation cephalosporins: structure-activity relationships. Journal of Antimicrobial Chemotherapy. 1982; 10(Suppl C): 1–10.
5.    Amidon GL, Lee HJ. Absorption of peptide and Peptidomimetics drugs. Annual Review of Pharmacology and Toxicology. 1994; 34(1): 321–41 .
6.    Döring F, Will J, Amasheh S, Clauss W, Ahlbrecht H, Daniel H. Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter. Journal of Biological Chemistry. 1998; 273(36):23211–8.
7.    Ezugwu JA, Okoro UC, Ezeokonkwo MA, Bhimapaka CR, Okafor SN, Ugwu DI, et al. Novel Leu-Val Based Dipeptide as Antimicrobial and Antimalarial Agents: Synthesis and Molecular Docking. Frontiers in Chemistry. 2020: 1-13.
8.    Wang CY, Liu S, Xie XN, Tan ZR. Regulation profile of the intestinal peptide transporter 1 (PepT1). Drug Design, Development and Therapy. 2017; 11: 3511-3517.
9.    Terada T, Inui K ichi. Recent advances in structural biology of peptide transporters. Current topics in Membranes. 2012; 70:257–274.  
10.    Katsura T, Inui K ichi. Intestinal absorption of drugs mediated by drug transporters: mechanisms and regulation. Drug Metabolism and Pharmacokinetic. 2003; 18(1): 1–15.
11.    Chadha N, Silakari O. Indoles: As multi-target directed ligands in medicinal chemistry. In: Key Heterocycle Cores for Designing Multi-targeting Molecules. Elsevier; 2018. p. 285–321.  
12.    Verma A, Joshi S, Singh D. Imidazole: having versatile biological activities. Journal of Chemistry. 2013; 2013.
13.    Noguchi T, Sekine M, Yokoo Y, Jung S, Imai N. Convenient Preparation of Primary Amides via Activation of Carboxylic Acids with Ethyl Chloroformate and Triethylamine under Mild Conditions. Chemstry Letters. 2013; 42(6): 580–2.  
14.    Alwan SM, Jabbar SS. Design, Synthesis and Preliminary Antimicrobial Evaluation of New Derivatives of Cephalexin. Iraqi Journal of Pharmaceutical Sciences. 2015; 24(1): 85–91.
15.    Azam SS, Abbasi SW. Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines. theoretical Biology and Medical modelling 2013; 10(1): 1–16.
16.    Boittier ED, Tang YY, Buckley ME, Schuurs ZP, Richard DJ, Gandhi NS. Assessing molecular docking tools to guide targeted drug discovery of CD38 inhibitors. International Journal of Molecular Sciences. 2020; 21(15),5183: 1-19.  
17.    Al-Farraj DA, Gawwad MRA, Mehmood A, Alsalme A, Darwish NM, Al-Zaqri N, et al. In-vitro antimicrobial activities of organic solvent extracts obtained from Dipcadi viride (L.) Moench., Journal of King Saud University-Science. 2020; 32(3): 1965–1968 .  
18.    Gonelimali FD, Lin J, Miao W, Xuan J, Charles F, Chen M, et al. Antimicrobial properties and mechanism of action of some plant extracts against food pathogens and spoilage microorganisms. Fronteir in Microbiology. 2018; 9: 1639: 1-9.
19.    Conda-Sheridan M, Krishnaiah M. Protecting groups in peptide synthesis. In: Peptide Synthesis. Springer; 2020: 111–128.DOI: 10.1007/978-1-0716-0227-0_7
20.    Molly B., Direct amidation of acid fluorides using germanium amides. Dalton Transactions. 2021; 50(13): 4490–4493.  
21.    Joullié MM, Lassen KM. Evolution of amide bond formation. Arkivoc . 2010; 8: 189–250.
22.    Jiang YY, Zhu L, Liang Y, Man X, Bi S. Mechanism of amide bond formation from carboxylic acids and amines promoted by 9-silafluorenyl dichloride derivatives The Journal of organic Chemistry. 2017; 82(17): 9087–9096.  
23.    Chen FMF, Benoiton NL. The preparation and reactions of mixed anhydrides of N-alkoxycarbonylamino acids. Canadian Journal of Chemistry. 1987; 65(3):619–625.
24.    Bernardo-García N, Mahasenan K v, Batuecas MT, Lee M, Hesek D, Petrackova D, et al. Allostery, recognition of nascent peptidoglycan, and cross-linking of the cell wall by the essential penicillin-binding protein 2x of Streptococcus pneumoniae. ACS Chemical Biology. 2018; 13(3): 694–702.
25.    Otero LH, Rojas-Altuve A, Llarrull LI, Carrasco-López C, Kumarasiri M, Lastochkin E, et al. How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function. Proceedings of the National Academy of Sciences. 2013; 110(42): 16808–16813.
26.    King DT, Wasney GA, Nosella M, Fong A, Strynadka NCJ. Escherichia coli penicillin-binding protein 1B: Structural insights into inhibition. Journal of Biological Chemistry. 2016; 292:979-993.
27.    Minhas GS, Newstead S. Structural basis for prodrug recognition by the SLC15 family of proton-coupled peptide transporters. Proceedings of the National Academy of Sciences. 2019; 116(3): 804–809.
28.    Awad M, Al-Hussaniy HA, Alburghaif AH, Tawfeeq KT. The role of COVID-19 in myopathy: incidence, causes, treatment, and prevention. Journal of Medicine & Life. 2022; 15(12).
29.    Salim Mahmood A, Ammoo AM, Ali MH, Hameed TM, Al-Hussaniy HA, Aljumaili AA, Al-Fallooji MH, Kadhim AH. Antiepileptic Effect of Neuroaid® on Strychnine-Induced Convulsions in Mice. Pharmaceuticals. 2022; 15(12): 1468.
30.    Al-Hussaniy HA, Mohammed ZN, Alburghaif AH, Naji MA. Panax ginseng as Antioxidant and Anti-inflammatory to reduce the Cardiotoxicity of Doxorubicin on rat module. Research Journal of Pharmacy and Technology. 2022; 15(10): 4594-600.
31.    Al-Kuraishy HM, Al-Hussaniy HA, Al-Gareeb AI, Negm WA, El-Kadem AH, Batiha GE, N Welson N, Mostafa-Hedeab G, Qasem AH, Conte-Junior CA. Combination of Panax ginseng C. A. Mey and Febuxostat Boasted Cardioprotective Effects Against Doxorubicin-Induced Acute Cardiotoxicity in Rats. Front Pharmacol. 2022; 13: 905828.
32.    Al-hussaniy HA, Altalebi RR, Albu-Rghaif AH, Abdul-Amir AG. The Use of PCR for Respiratory Virus Detection on the Diagnosis and Treatment Decision of Respiratory Tract Infections in Iraq. Journal of Pure and Applied Microbiology. 2022; 16(1): 201-7.
33.    Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NA, Alexiou A, Batiha GE. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality. International Immunopharmacology. 2022:108516.
34.    Al-hussainy HA, AL-Biati HA, Ali IS. The Effect of Nefopam Hydrochloride on the Liver, Heart, and Brain of Rats: Acute Toxicity and Mechanisms of Nefopam Toxicity. Journal of Pharmaceutical Negative Results¦ Volume. 2022; 13(3): 393.
35.    Al-Hussaniy HA. The Effect of MicroRNA-409-3p for Treatment and Response to Tumor Proliferation of Lung Cancer Cell Lines (In Vitro). Asian Pacific Journal of Cancer Prevention. 2022; 23(9): 3151-6.
36.    Al-Hussaniy HA, Alburghaif AH, Naji MA. Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions. Journal of Medicine and Life. 2021; 14(5): 600.
37.    Alkuraishy HM, Al-Gareeb AI, Al-hussaniy HA. Doxorubicin-induced cardiotoxicity: molecular mechanism and protection by conventional drugs and natural products. Int J Clin Oncol Cancer Res. 2017; 2(2): 31-44.
38.    Al-hussaniy HA. Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes. Journal of Medicine and Life. 2023;16(1):42.
39.    Salman OD, Ibrahim SK, Rashid RG, Al-Hussaniy HA. The role of laboratory test biomarkers in diagnosis, risk assessment, and monitoring of COVID-19 patients. Journal of Clinical Trials and Experimental Investigations. 2023;2(1):7-14.
40.    Al-Hussaniy HA, Al-kuraishy AA, Jalil HJ. Evaluation of the efficacy of adrenergic neurons inhibition through various surgical and therapeutic regimens on controlling blood pressure and circadian rhythm in patients with uncontrolled hypertension. Journal of Clinical Trials and Experimental Investigations. 2022; 1(3): 106-13.
41.    Feona George, Greeshma Raju, Jency Xavier, Jenisha J B, Shilpa S, Asha Francis. Effectiveness of Self Instructional Module on knowledge regarding Methicillin Resistant (MRSA) infection among staff nurses of a selected Hospital, Kollam. Asian Journal of Nursing Education and Research. 2022; 12(1):105-7.
42.    D. M. Suyoga Vardhan, H. K. Kumara, H. Pavan Kumar, D. Channe Gowda. Urea and Thiourea Derivatives of Dipeptides Conjugated Piperazine Analogue as A New Class of AGE’s Inhibitors: Synthesis and Molecular Docking Studies. Asian J. Research Chem. 2017; 10(4):459-469.
43.    D. M. Suyoga Vardhan, H. K. Kumara, H. Pavan Kumar, D. Channe Gowda. Urea and Thiourea Derivatives of Dipeptides Conjugated Piperazine Analogue as A New Class of AGE’s Inhibitors: Synthesis and Molecular Docking Studies. Asian J. Research Chem. 2017; 10(4):459-469.
44.    Manjunath Sangappa, Padma Thiagarajan. Isolation and Screening of Soil Penicillium sp VIT-2012 Metabolites against Methicillin Resistant Staphylococcus aureus. Research J. Pharm. and Tech. 2013; 6(12):  1340-1349.
45.    Sharma. Shalini, Upadhayay U. M, Mistry Sunil. Antimicrobial Activity of Extracts against MRSA. Research J. Pharm. and Tech 2016; 9(12): 2283-2286.
46.    Subashree Rathi Selvan, Dhanraj Ganapathy. Efficacy of Fifth Generation Cephalosporins against Methicillin-Resistant Staphylococcus aureus- A Review. Research J. Pharm. and Tech 2016; 9(10): 1815-1818.
47.    Al-hussaniy H, Kadhim Z. Methicillin-Resistant Staphylococcus aureus and New Delhi Metallo beta-lactamases-types of antibiotic resistance, methods of prevention. Medical and Pharmaceutical Journal. 2022; 1(1): 14-24.
48.    Naji MA, Alburghaif AH, Saleh NK, Al-hussaniy H. Patient expectations regarding consultation with a family doctor: a cross-sectional study. Medical and Pharmaceutical Journal. 2022; 1(1): 35-40.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available